Dr. Reem Olaby is a pharmacist, scientist, and higher-education leader actively engaged in curriculum reform, faculty development, and academic governance. She currently serves as the director of pharmacology at College of Veterinary Medicine- Lincoln Memorial University in Orange Park, Florida.

Her scholarly work focuses on the genetic, epigenetic, and proteomic underpinnings of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), Fragile X syndrome (FXS), and Fragile X–associated tremor/ataxia syndrome (FXTAS).

She is dedicated to translating molecular research into impactful education strategies, clinical training initiatives, and interdisciplinary collaboration.